Contrafect Corp Is A Clinical Stage Biotechnology Company Based In Yonkersnew Yorkthe Company Specializes In Discovering And Developing Biologic Therapiesparticularly Direct Lytic Agentsdlas Aimed At Treating Life Threateningdrug Resistant Infectious Diseases That Often Require Hospital Care The Product Pipeline Includes Exebacasecf 301 Which Targets Methicillin Resistant Staphylococcus Aureusmrsabloodstream Infections And Chronic Prosthetic Joint Infectionsanother Candidatecf 370Is Designed To Combat A Range Of Gram Negative Bacteriaincluding Pseudomonas Aeruginosa And Klebsiella Pneumoniaeadditionallythe Amurins Are Part Of Their Efforts To Address Severe Infections
